Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Invasive”

627 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 627 results

Not applicableActive Not RecruitingNCT07584213
What this trial is testing

The Association Between Blood Routine Parameters and Breast Cancer Prognosis

Who this might be right for
Breast Cancer Invasive
Wenjin Yin 2,946
Testing effectiveness (Phase 2)Study completedNCT00525759
What this trial is testing

Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast Cancer

Who this might be right for
Breast Cancer
Sheffield Teaching Hospitals NHS Foundation Trust 40
Large-scale testing (Phase 3)Looking for participantsNCT03201861
What this trial is testing

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Duct Carcinoma of Breast
RenJi Hospital 762
Not applicableLooking for participantsNCT06716073
What this trial is testing

Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial

Who this might be right for
Breast Cancer Invasive
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1,380
Not applicableLooking for participantsNCT07071272
What this trial is testing

Non-inferiority Study of Contrast-enhanced Digital Mammography (CEDM) vs Magnetic Resonance Imaging (MRI) in Terms of Diagnostic Accuracy in Patients Undergoing Preoperative Staging of Established Invasive Breast Cancer

Who this might be right for
Breast Cancer
Azienda Ospedaliera Universitaria Integrata Verona 216
Testing effectiveness (Phase 2)Study completedNCT00977275
What this trial is testing

Treatment of T1N0 Invasive Breast Carcinoma by Local Excision Implant

Who this might be right for
Breast Cancer
Massachusetts General Hospital 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT02764541
What this trial is testing

Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 195
Testing effectiveness (Phase 2)Study completedNCT05960201
What this trial is testing

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma

Who this might be right for
Carcinoma, Lobular
Asan Medical Center 23
Large-scale testing (Phase 3)Study completedNCT00088010
What this trial is testing

Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

Who this might be right for
Osteoporosis, Postmenopausal
Eli Lilly and Company 9,369
Early research (Phase 1)Ended earlyNCT04296942
What this trial is testing

BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)

Who this might be right for
Breast CancerTriple Negative Breast CancerHER2+ Breast Cancer+2 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)UnknownNCT02333890
What this trial is testing

Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer

Who this might be right for
Breast CancerInvasive Breast Cancer
Ottawa Hospital Research Institute 60
Large-scale testing (Phase 3)Study completedNCT00002967
What this trial is testing

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc
Testing effectiveness (Phase 2)Looking for participantsNCT05861271
What this trial is testing

Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer

Who this might be right for
Breast Cancer Stage I
Fudan University 1,008
Not applicableActive Not RecruitingNCT04897009
What this trial is testing

Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer

Who this might be right for
Invasive Breast Carcinoma
Mayo Clinic 38
Testing effectiveness (Phase 2)Looking for participantsNCT07102381
What this trial is testing

Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerBreast Cancer
Jazz Pharmaceuticals 125
Not applicableStudy completedNCT03375892
What this trial is testing

The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure

Who this might be right for
Breast CancerDuctal Carcinoma in SituInvasive Breast Cancer
Medical College of Wisconsin 11
Not applicableActive Not RecruitingNCT06053775
What this trial is testing

Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP)

Who this might be right for
Depressive SymptomsCognitive Impairment
University of Santiago de Compostela 82
Not applicableUnknownNCT00536718
What this trial is testing

Genetics of Women With Lobular Carcinoma in Situ of the Breast

Who this might be right for
Breast Cancer
National Cancer Research Network 3,000
Not applicableLooking for participantsNCT05877859
What this trial is testing

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

Who this might be right for
Breast Cancer Triple NegativeBreast Cancer Stage IIBreast Cancer Stage III+1 more
Emory University 10
Not applicableStudy completedNCT02244580
What this trial is testing

Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit "MammaTyperTM"

Who this might be right for
Invasive Breast Cancer
BioNTech Diagnostics GmbH 1,010
Load More Results